This Article Full Text Full Text (PDF) Other Versions of this Article: AAC.00831-06v1 51/6/2105    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Durand-Gasselin, L. Articles by Grassi, J. Search for Related Content PubMed PubMed Citation Articles by Durand-Gasselin, L. Articles by Grassi, J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, June 2007, p. 2105-2111, Vol. 51, No. 6
0066-4804/07/$08.00+0     doi:10.1128/AAC.00831-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Evidence and Possible Consequences of the Phosphorylation of Nucleoside Reverse Transcriptase Inhibitors in Human Red Blood Cells

CEA, iBiTec-S, Service de Pharmacologie et d'Immunoanalyse, Gif sur Yvette, F-91191, France

Received 10 July 2006/ Returned for modification 6 October 2006/ Accepted 5 April 2007

The intracellular metabolism of nucleoside reverse transcriptase inhibitors (NRTI) in mononuclear cells has been thoroughly studied, but that in red blood cells (RBC) has been disregarded. However, the phosphorylation of other analogous nucleosides (in particular, ribavirin) has been described previously. In this study, we investigated for the first time the phosphorylation of NRTI in human RBC. The presence of intracellular zidovudine (AZT) monophosphate, AZT triphosphate, lamivudine (3TC) triphosphate, and tenofovir (TFV) diphosphate, as well as endogenous dATP, dGTP, and dTTP, in RBC collected from human immunodeficiency virus-infected patients was examined. We observed evidence of a selective phosphorylation of 3TC, TFV, and endogenous purine deoxynucleosides to generate their triphosphate moieties. Conversely, no trace of AZT phosphate metabolites was found, and only faint dTTP signals were visible. A comparison of intracellular TFV diphosphate and 3TC triphosphate levels in RBC and peripheral blood mononuclear cells (PBMC) further highlighted the specificity of NRTI metabolism in each cell type. These findings raise the issue of RBC involvement in drug-drug interaction, drug pharmacokinetics, and drug-induced toxicity. Moreover, the typical preparation of PBMC samples by gradient density centrifugation does not prevent their contamination with RBC. We demonstrated that the presence of RBC within PBMC hampers an accurate determination of intracellular TFV diphosphate and dATP levels in clinical PBMC samples. Thus, we recommend removing RBC during PBMC preparation by using an ammonium chloride solution to enhance both the accuracy and the precision of intracellular drug monitoring.

Published ahead of print on 16 April 2007.

This article has been cited by other articles:

• Van Rompay, K. K. A., Durand-Gasselin, L., Brignolo, L. L., Ray, A. S., Abel, K., Cihlar, T., Spinner, A., Jerome, C., Moore, J., Kearney, B. P., Marthas, M. L., Reiser, H., Bischofberger, N. (2008). Chronic Administration of Tenofovir to Rhesus Macaques from Infancy through Adulthood and Pregnancy: Summary of Pharmacokinetics and Biological and Virological Effects. Antimicrob. Agents Chemother. 52: 3144-3160 [Abstract] [Full Text]  
• Durand-Gasselin, L., Pruvost, A., Dehee, A., Vaudre, G., Tabone, M.-D., Grassi, J., Leverger, G., Garbarg-Chenon, A., Benech, H., Dollfus, C. (2008). High Levels of Zidovudine (AZT) and Its Intracellular Phosphate Metabolites in AZT- and AZT-Lamivudine-Treated Newborns of Human Immunodeficiency Virus-Infected Mothers. Antimicrob. Agents Chemother. 52: 2555-2563 [Abstract] [Full Text]